Topic Review
Pleiotropic Effects of Statins
An emergent approach to bacterial infection is the use of host rather than bacterial-directed strategies. This approach has the potential to improve efficacy in especially challenging infection settings, including chronic, recurrent infection due to intracellular pathogens. For nearly two decades, the pleiotropic effects of statin drugs have been examined for therapeutic usefulness beyond the treatment of hypercholesterolemia. 
  • 440
  • 13 Dec 2021
Topic Review
Piperacillin–Tazobactam Plus Vancomycin-Associated Acute Kidney Injury
Numerous observational studies and meta-analyses have suggested that combination therapy consisting of piperacillin–tazobactam (TZP) and vancomycin (VAN) augments acute kidney injury (AKI) risk when compared to viable alternatives, such as cefepime–vancomycin (FEP–VAN) and meropenem–VAN.
  • 440
  • 01 Sep 2022
Topic Review
Nanotechnology Platform for Advancing Vaccine Development Against COVID-19
The COVID-19 pandemic has had a profound impact on societies, public health, healthcare systems, and the world economy. Vaccination emerged as the most effective strategy to combat this infectious disease. For vaccination strategies, any conventional vaccine approach using attenuated live or inactivated/engineered virus, as well as other approaches, typically requires years of research and assessment. However, the urgency of the situation promoted a faster and more effective approach to vaccine development against COVID-19. The role of nanotechnology in designing, manufacturing, boosting, and delivering vaccines to the host to counter this virus was unquestionably valued and assessed.
  • 439
  • 26 Dec 2023
Topic Review
Hepatitis B Virus Genotypes and Human Populations
Hepatitis B virus (HBV) is a challenge for global health services, affecting millions and leading thousands to end-stage liver disease each year. HBV is classified into ten genotypes (A to J) and more than 40 sub-genotypes based on a genomic divergence of 8% and 4% (intra-genotype variation), respectively.
  • 438
  • 26 Sep 2023
Topic Review
Mast Cells against Fungal Host Defense
Mast cells take part in host defense against various microorganisms as they are numerous at the portal of infection, exert several essential mechanisms of pathogen destruction, and they express pattern recognition receptors. MCs can support immune responses to fungi and their specific constituents through initiated degranulation, synthesis and release of cytokines, chemokines, mediators, and generation of reactive oxygen species (ROS), as well as immune cells' recruitment, phagocytosis, or formation of extracellular DNA traps. 
  • 437
  • 06 Dec 2021
Topic Review
Japanese Encephalitis Virus Clinical Features in Humans
Japanese encephalitis virus (JEV), a zoonotic flavivirus, is principally transmitted by hematophagous mosquitoes, continually between susceptible animals and incidentally from those animals to humans.
  • 436
  • 05 Jun 2023
Topic Review
Escherichia coli Antimicrobial Resistance in Humans
To date, the scientific literature on health variables for Escherichia coli antimicrobial resistance (AMR) has been investigated throughout several systematic reviews, often with a focus on only one aspect of the One Health variables: human, animal, or environment.
  • 436
  • 03 Jan 2024
Topic Review
Fecal Microbiota Transplantation in Non-Gastroenterological Diseases
The gut microbiota has a critical function in human health, and its various disorders are associated with the development of particular diseases. Disruption of the gut microbiota may lead to both gastrointestinal and non-gastrointestinal diseases, such as cancer, metabolic syndrome, or neuropsychiatric diseases. In this context, it is not surprising that gut microbiota modification methods may constitute a therapy whose potential has not yet been fully investigated. In this regard, the most interesting method is thought to be fecal microbiota transplantation, which consists of the simultaneous replacement of the intestinal microbiota of a sick recipient with fecal material from a healthy donor. 
  • 434
  • 24 Feb 2022
Topic Review
Pediatric Tuberculosis Management
Managing pediatric tuberculosis (TB) remains a public health problem requiring urgent and long-lasting solutions as TB is one of the top ten causes of ill health and death in children as well as adolescents universally. Minors are particularly susceptible to this severe illness that can be fatal post-infection or even serve as reservoirs for future disease outbreaks
  • 434
  • 01 Sep 2022
Topic Review
Technologies for Plasmon-Based Fluorescence Enhancement
Fluorescence is a widely used phenomenon in various scientific and technological fields, including biology, chemistry, medicine, and materials science. The fluorescence signal provides valuable information about molecular interactions, concentrations, and structural changes. Fluorescence exhibits numerous valuable applications, encompassing the detection of single molecules, fluorescence nanoscopy, biological labeling, and optoelectronic device functionality, among many others. Fluorescence enhancement is imperative for enhancing the sensitivity and precision of a wide range of scientific and technological applications that heavily rely on fluorescence detection. It is a crucial requirement to elevate the performance and reliability of these applications.
  • 434
  • 11 Mar 2024
Topic Review
Convalescent Plasma Transfusion for COVID‐19
More than one year into the novel coronavirus disease 2019 (COVID-19) pandemic, healthcare systems across the world continue to be overwhelmed with soaring daily cases. The treatment spectrum primarily includes ventilation support augmented with repurposed drugs and/or convalescent plasma transfusion (CPT) from recovered COVID-19 patients. CPT is a promising COVID-19 therapeutic option that merits internationally coordinated RCTs to achieve a scientific risk-benefit consensus. 
  • 433
  • 24 May 2021
Topic Review
Therapy of Chronic Hepatitis D
Peg-IFN is the only therapy for chronic hepatitis D (CHD) recommended by professional societies (not approved by Drug Regulatory Agencies); it has limited efficacy, and valid treatment of CHD has so far remained an unmet medical need
  • 432
  • 10 Mar 2022
Topic Review
Treatment of Clostridioides difficile Infection
Clostridioides difficile is the most important cause of healthcare-associated diarrhea in the United States. The high incidence and recurrence rates of C. difficile infection (CDI), associated with high morbidity and mortality, pose a public health challenge. Although antibiotics targeting C. difficile bacteria are the first treatment choice, antibiotics also disrupt the indigenous gut flora and, therefore, create an environment that is favorable for recurrent CDI. The challenge of treating CDI is further exacerbated by the rise of antibiotic-resistant strains of C. difficile, placing it among the top five most urgent antibiotic resistance threats in the USA. The evolution of antibiotic resistance in C. difficile involves the acquisition of new resistance mechanisms, which can be shared among various bacterial species and different C. difficile strains within clinical and community settings.
  • 432
  • 01 Feb 2024
Topic Review
Diagnostic Approaches for Epstein–Barr Virus
Epstein–Barr virus (EBV) is the causative agent of many diseases including infectious mononucleosis (IM), and it is associated with different subtypes of lymphoma, sarcoma and carcinoma such as Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, nasopharyngeal carcinoma, and gastric carcinoma. With the advent of improved laboratory tests for EBV, a timelier and accurate diagnosis could be made to aid better prognosis and effective treatment. For histopathological lesions, the in situ hybridization (ISH) of EBV-encoded RNA (EBER) in biopsy tissues remains the gold standard for detecting EBV.
  • 431
  • 23 Mar 2022
Topic Review
Human Monkeypox
Recently, numerous cases of monkeypox were reported from several non-endemic countries in Europe, North America, and Oceania, suggesting an unusual and alarming public health issue, particularly considering that the disease is not directly related to human or animal travels. Attention is currently being drawn to this phenomenon since more than 70% of the global population is no longer vaccinated against smallpox.
  • 431
  • 24 Aug 2022
Topic Review
Interferon-Gamma Release Assays in Physiologically Immunocompromised People
Interferon-gamma release assays (IGRAs) are widely used in the diagnosis of Mycobacterium tuberculosis (M. tuberculosis) infection by detecting interferon-γ released by previously sensitized T-cells in-vitro. The performance of IGRAs is different in population with physiologically Immunocompromised factors.
  • 430
  • 15 Apr 2022
Topic Review
Human Streptococcus suis Disease in Southeast Asia
The public health systems of Southeast Asian countries are financially challenged by a comparatively higher incidence of human S. suis infections than other geographical areas. Efforts to improve practices in production settings, including improved meat inspection regulations, prevention of the slaughtering of non-healthy pigs, and enhanced hygiene practices at processing facilities, along with improvements in the pork supply chain, all appear promising for reducing food cross-contamination with S. suis. 
  • 430
  • 27 Apr 2022
Topic Review
Technology-Enabled Health Interventions for Adolescents with HIV
Adolescents living with HIV (ALHIV) are challenged to remain adherent and engaged in HIV care. Technology-enabled interventions can be used to optimize healthcare delivery to adolescents. The largest proportion of ALHIV resides in sub-Saharan Africa. There is weak evidence that technology-enabled health interventions for ALHIV in low and middle-income countries (LMIC) improve treatment outcomes. However, most interventions appear to be acceptable and feasible. 
  • 430
  • 17 Apr 2023
Topic Review
COVID-19 Vaccinations
Vaccination, in general, is effective in protecting high-risk populations against severe COVID-19 infections and COVID-19-associated mortality. A summary of special population groups with regards to their features, prognosis of infection, and vaccination decision based on current evidence is listed in. Patients without contraindications should be prioritized for vaccination under the careful supervision of healthcare workers after balancing the benefits and risks of vaccinations.
  • 429
  • 27 Oct 2021
Topic Review
Hematologic Malignancies in COVID-19 Pandemic
Obesity is epidemiologically and likely, causally related to various hematological cancers, while both conditions may predispose to severe SARS-CoV-2 infection. The COVID-19 pandemic brought about a variety of obstacles with respect to numerous aspects in the management of hematological malignancies. Patients with hematologic malignancies faced a variety of challenges, pertinent to the nature of an underlying hematologic disorder itself as well as its therapy as a risk factor for severe SARS-CoV-2 infection, suboptimal vaccine efficacy and the need for uninterrupted medical observation and continued therapy. Obesity constitutes another factor which was acknowledged since the early days of the pandemic that predisposed people to severe COVID-19, and shares a likely causal link with the pathogenesis of a broad spectrum of hematologic cancers.
  • 429
  • 25 May 2022
  • Page
  • of
  • 32
ScholarVision Creations